Cargando…
In vivo monitoring of sorafenib therapy effects on experimental prostate carcinomas using dynamic contrast-enhanced MRI and macromolecular contrast media
Purpose: To investigate dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) with macromolecular contrast media (MMCM) to monitor the effects of the multikinase inhibitor sorafenib on subcutaneous prostate carcinomas in rats with immunohistochemical validation. Materials and methods: Copen...
Autores principales: | Cyran, Clemens C., Schwarz, Bettina, Paprottka, Philipp M., Sourbron, Steven, von Einem, Jobst C., Dietrich, Olaf, Hinkel, Rabea, Clevert, Dirk A., Bruns, Christiane J., Reiser, Maximilian F., Nikolaou, Konstantin, Wintersperger, Bernd J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
e-Med
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3876822/ https://www.ncbi.nlm.nih.gov/pubmed/24380871 http://dx.doi.org/10.1102/1470-7330.2013.0049 |
Ejemplares similares
-
Reducing tumor growth and angiogenesis using a triple therapy measured with Contrast-enhanced ultrasound (CEUS)
por: Paprottka, Philipp Marius, et al.
Publicado: (2015) -
Regorafenib Effects on Human Colon Carcinoma Xenografts Monitored by Dynamic Contrast-Enhanced Computed Tomography with Immunohistochemical Validation
por: Cyran, Clemens C., et al.
Publicado: (2013) -
Ex Vivo Perfusion-Simulation Measurements of Microbubbles as a Scattering Contrast Agent for Grating-Based X-Ray Dark-Field Imaging
por: Velroyen, Astrid, et al.
Publicado: (2015) -
Perfusion MRI for monitoring therapy effects in experimental chronic limb ischemia
por: Kramer, Harald, et al.
Publicado: (2009) -
Visualization, imaging and new preclinical diagnostics in radiation oncology
por: Cyran, Clemens C, et al.
Publicado: (2014)